Peterson E M, Xu K, Holland K D, McKeon A C, Rothman S M, Ferrendelli J A, Covey D F
Department of Molecular Biology, Washington University School of Medicine, St. Louis, Missouri 63110.
J Med Chem. 1994 Jan 21;37(2):275-86. doi: 10.1021/jm00028a011.
To further study the putative gamma-butyrolactone site of the GABAA/chloride channel complex, constrained derivatives of convulsant and anticonvulsant alpha,alpha-disubstituted gamma-butyrolactones (alpha-spirocyclopropyl- and alpha-spirocyclopentyl-gamma-butyrolactones) were synthesized and evaluated biologically. Most of the spirocyclopropyl agents were anticonvulsants when tested against pentylenetetrazole-induced seizures in mice. These agents effectively displaced 35[S]-tert-butylbicyclophosphorothionate (35[S]-TBPS), a ligand for the picrotoxin binding site of the GABAA/chloride channel, from rat neuronal membranes and affected the GABA-mediated current in hippocampal neurons. The monomethyl-substituted spirocyclopropyl agent with a methyl group cis to the carbonyl (15) potentiates GABA-induced current whereas the trans derivative (16) blocks the current. The only anticonvulsant in the spirocyclopentyl series was the unsubstituted spirocyclopentyl compound 2. All the other substituted spirocyclopentyl targets were inactive in vivo at the highest dose tested except for convulsant 9, which has a trans 2,5-dimethyl-substituted cyclopentyl ring. All the spirocyclopentyl derivatives displaced 35[S]-TBPS from rat neuronal membranes very effectively, and they also all potentiated GABA-induced chloride current except for convulsant 9 which blocked the current. From the data obtained in this investigation, it appears that when the volume occupied above and below the lactone ring is as large as that occupied by spirocyclopentyl agent 9, convulsant activity is observed. Groups with less volume in these areas either are inactive in the behavioral test or have anticonvulsant activity. When bound to the GABAA/chloride channel, the larger molecules may stabilize the closed state of the channel whereas the smaller molecules may stabilize the open state.
为进一步研究GABAA/氯离子通道复合物假定的γ-丁内酯位点,合成了惊厥剂和抗惊厥剂α,α-二取代γ-丁内酯(α-螺环丙基-和α-螺环戊基-γ-丁内酯)的受限衍生物并进行生物学评价。大多数螺环丙基药物在针对小鼠戊四氮诱导的惊厥进行测试时为抗惊厥剂。这些药物能有效地将35[S]-叔丁基双环磷硫代酸酯(35[S]-TBPS),一种GABAA/氯离子通道苦味毒结合位点的配体,从大鼠神经元膜上置换下来,并影响海马神经元中GABA介导的电流。羰基顺式带有甲基的单甲基取代螺环丙基药物(15)增强GABA诱导的电流,而反式衍生物(16)则阻断电流。螺环戊基系列中唯一的抗惊厥剂是未取代的螺环戊基化合物2。除了惊厥剂9(其具有反式2,5-二甲基取代的环戊基环)外,所有其他取代的螺环戊基目标在测试的最高剂量下在体内均无活性。所有螺环戊基衍生物都能非常有效地从大鼠神经元膜上置换35[S]-TBPS,并且除了惊厥剂9阻断电流外,它们也都增强GABA诱导的氯离子电流。从该研究获得的数据来看,似乎当内酯环上下占据的体积与螺环戊基药物9占据的体积一样大时,就会观察到惊厥活性。这些区域中体积较小的基团要么在行为测试中无活性,要么具有抗惊厥活性。当与GABAA/氯离子通道结合时,较大的分子可能稳定通道的关闭状态,而较小的分子可能稳定通道的开放状态。